We are live on ! Find out more
TROVW

TrovaGene, Inc. Warrant
TROVW

Delisted

TROVW was delisted on the 30th of May, 2017.

Back to rankings

4 hedge funds and large institutions have $656K invested in TrovaGene, Inc. Warrant in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

42% less call options, than puts

Call options by funds: $26K | Put options by funds: $45K

44% less capital invested

Capital invested by funds: $1.18M → $656K (-$524K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
–
Calls
$26K
Puts
$45K
Net Calls
-$19K
Net Calls Change
-$122K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$15K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$36.6K
2
UBS Group
UBS Group
Switzerland
-$1.41K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$642K -$36.6K -18,200 -4%
Morgan Stanley
2
Morgan Stanley
New York
$14K +$15K +7,434 +226%
UBS Group
3
UBS Group
Switzerland
– -$1.41K -703 -86%

TROVW Hedge Fund Activity: Q3 2016 in Review

4 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q3 2016, worth a combined $656K — down 44% from $1.18M a quarter earlier.

Fund positioning in TROVW was balanced in Q3 2016: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $15K. The largest seller was Millennium Management, cutting an estimated $36.6K.

  • 4 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $656K of TrovaGene, Inc. Warrant stock for Q3 2016, down 44% quarter-over-quarter.
  • 0 funds opened new TrovaGene, Inc. Warrant positions in Q3 2016 and 0 closed out.
  • The largest TrovaGene, Inc. Warrant buyer in Q3 2016 was Morgan Stanley, an estimated $15K added.
  • The largest TrovaGene, Inc. Warrant seller in Q3 2016 was Millennium Management, an estimated $36.6K sold.

Based on aggregated 13F filings for Q3 2016.